Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses

Favipiravir is approved in Japan to treat novel or re-emerging influenza viruses, and is active against a broad spectrum of RNA viruses, including Ebola. Ribavirin is the only other licensed drug with activity against multiple RNA viruses. Recent studies show that ribavirin and favipiravir act syner...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antiviral Res
Main Authors: Westover, Jonna B., Sefing, Eric J., Bailey, Kevin W., Van Wettere, Arnaud J., Jung, Kie-Hoon, Dagley, Ashley, Wandersee, Luci, Downs, Brittney, Smee, Donald F., Furuta, Yousuke, Bray, Mike, Gowen, Brian B.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4724333/
https://ncbi.nlm.nih.gov/pubmed/26711718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2015.12.006
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki